Capricor Therapeutics
CAPR
NASDAQ
IPO2002
about CAPR
Capricor Therapeutics specializes in developing innovative therapies for rare diseases and neurodegenerative conditions through cutting-edge cell-based and gene therapy methods.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $26.74 | $28.63 | $26.01 | $1.23B | 7.04M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.54 | n/a | n/a | 0% | 0% | 0% |